Stand Up To Cancer Commits to Making Clinical Trials More Diverse
Lack of access and mistrust often keep diverse patients from participating in clinical trials. Nonprofit group Stand Up To Cancer wants to change that.
Lack of access and mistrust often keep diverse patients from participating in clinical trials. Nonprofit group Stand Up To Cancer wants to change that.
Stand Up To Cancer has launched two initiatives to increase minority representation in cancer clinical trials by amending its grant application requirements and funding a new research team focused on diversity and inclusion.
Cancer research is rapidly advancing and mortality from the disease is dropping, but not all patients are benefiting equally.
Dr. Edith Perez, a Mayo Clinic oncologist and chair of the Stand Up To Cancer committee for health equity in cancer clinical trials today announced a new Stand Up To Cancer Health Equity Initiative aimed at reducing disparities among racial groups in cancer clinical trials.
Although we still have a long way to go in the fight against cancer, over 50 drugs have been approved for cancer in the last three years. That’s good news – until you take a closer look at the data.
She shared how she dealt with her mother’s breast cancer diagnosis.
A half-century after America’s Civil Rights Movement exposed gross disparities in healthcare among minorities, the issue still plagues the medical community.
Rusty Robertson, Co-Founder of Stand Up To Cancer and SU2C Council of Founders and Advisors shares her story.
Nearly 10 years after Farrah Fawcett’s death, the Farrah Fawcett Foundation will honor cancer survivor and Desperate Housewives actress Marcia Cross as well as writer and philanthropist Mary Willard, the late wife of Fred Willard.
Matt Damon stands up with a poster saying “Dad.” Joe Manganiello’s says “Loved Ones.” In a video released today ahead of MLB’s Stand Up To Cancer (SU2C) placard moment, these stars are standing up and holding up the names of people in their lives who have been affected by cancer.